Precision Oncology in Melanoma and Skin Cancer Surgery.

Abstract excerpt

There has been perhaps no greater advance in the prognosis of solid tumors in the last decade than for patients with metastatic melanoma. This is due to significant improvements in treatment based on two key components of melanoma tumor biology (1) the identification of driver mutations with therapeutic potential and (2) the mechanistic understanding of a tumor-specific immune response. With breakthrough findings...

Topics

• Humans
• Melanoma
• Skin Neoplasms
• Precision Medicine
• Mutation
• Molecular Targeted Therapy
• Immunotherapy